NIFTY 50 22795.9 ▼ (0.51%)
NIFTY NEXT 50 60466.8 ▼ (0.94%)
NIFTY 100 23274.05 ▼ (0.59%)
NIFTY MIDCAP 100 50486.2 ▼ (1.32%)
NIFTY SMALLCAP 100 15636.9 ▼ (0.7%)
NIFTY SMALLCAP 250 14683.4 ▼ (0.57%)
NIFTY MIDCAP SELECT 11198.9 ▼ (1.69%)
NIFTY TOTAL MARKET 11634.25 ▼ (0.67%)
NIFTY BANK 48981.2 ▼ (0.72%)
SENSEX 75311.06 ▼ (0.56%)
BSE BANKEX 55718.18 ▼ (0.82%)

EVEXIA LIFECARE ‘s Q3 2024-25 Latest News: Profit Grows by 1100% YoY

February 15, 2025February 15, 2025| adminadmin| 0 Comments| 5:05 am
[fetch_key]
Categories:

Share the post "EVEXIA LIFECARE ‘s Q3 2024-25 Latest News: Profit Grows by 1100% YoY"

  • Facebook
  • LinkedIn
  • X
  • Tumblr
  • WhatsApp
  • TelegramTelegram
  • Email

Highlights

🔹 The presented financial data is Consolidated to provide a comprehensive overview of the company performance.
🔹 Sales over the Year and quarter: The company experienced a substantial growth of 214.36 % in the past year, decrease in net sales/revenue by -22.41 %.
🔹 Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 2100 %. Marginal increase in other income during this quarter, up by 104.08%.
🔹 Profit over the Year and quarter: Significant improvement in profitability for EVEXIA LIFECARE LIMITED. Notable increase of 742.86 % in net profit Year to Year, EVEXIA LIFECARE LIMITED’s profitability dropped by -83.75 % Quarter to Quarter.
🔹 EPS over the Year and quarter: EPS increased by 0 % in previous quarter. Positive impact on shareholders.

In our extensive review of EVEXIA LIFECARE LIMITED, we incorporate a thorough examination of the company’s market trends, investment risks, and growth opportunities. The analysis highlights how external economic factors, regulatory changes, and technological advancements could impact the company’s future performance. Additionally, it includes a detailed look at the company’s dividend policy and its commitment to returning value to shareholders. This holistic approach to understanding EVEXIA LIFECARE LIMITED’s financial and strategic outlook is designed to assist investors in crafting a robust investment portfolio that aligns with their financial goals and risk tolerance.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 6.903 Cr Rs. 27.969 Cr Rs. 21.7 Cr -22.41 % + 214.36 %
Expenses Rs. 6.8 Cr Rs. 26.88 Cr Rs. 21.53 Cr -19.9 % + 216.62 %
Operating Profit Rs. 0.1 Cr Rs. 1.09 Cr Rs. 0.17 Cr -84.4 % + 70 %
OPM % 1.45 % 3.9 % 0.78 % -3.12 % -0.67 %
Other Income Rs. -0.005 Cr Rs. 0.049 Cr Rs. 0.1 Cr + 104.08 % + 2100 %
Interest Rs. 0.01 Cr Rs. 0.05 Cr Rs. 0 Cr 0 % 0 %
Depreciation Rs. 0.07 Cr Rs. 0.11 Cr Rs. 0.11 Cr + 0 % + 57.14 %
Profit before tax Rs. 0.02 Cr Rs. 0.98 Cr Rs. 0.16 Cr -83.67 % + 700 %
Tax % 26.32 % 25.99 % 25.79 % -0.2 % -0.53 %
Net Profit Rs. 0.01 Cr Rs. 0.73 Cr Rs. 0.12 Cr -83.56 % + 1100 %
EPS in Rs Rs. 0 Rs. 0.01 Rs. 0.01 + 0 % 0 %


Today, we’re looking at EVEXIA LIFECARE LIMITED’s financial performance for the Q3(Dec 2024-25).Starting with the top line, the company reported a robust year-over-year sales growth of 214.36 %. However, it did see a marginal slip of -22.41 % from the previous quarter. Expenses decreased slightly by -19.9 % quarter-on-quarter, aligning with the annual rise of 216.62 %. Operating profit, while up 70 % compared to last year, faced a quarter-on-quarter dip of -84.4 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -0.67 %, but a shrinkage of -3.12 % sequentially. Other income rose by 104.08 % compared to the last quarter, despite an annual growth of 2100 %. Depreciation costs climbed by 0 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 57.14 %. Profit before tax grew annually by 700 % but saw a reduction from the preceding quarter by -83.67 %.
Tax expenses as a percentage of profits decreased slightly by -0.53 % compared to last year, with a more notable quarter-on-quarter decrease of -0.2 %. Net profit rose by 1100 % year-on-year but witnessed a -83.56 % contraction from the last quarter. but a quarterly rise of 0 %. In summary, EVEXIA LIFECARE LIMITED’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 6.903 Cr Rs. 27.969 Cr Rs. 21.7 Cr -22.41 % + 214.36 %
Expenses Rs. 6.8 Cr Rs. 26.88 Cr Rs. 21.53 Cr -19.9 % + 216.62 %
Operating Profit Rs. 0.1 Cr Rs. 1.09 Cr Rs. 0.17 Cr -84.4 % + 70 %
Net Profit Rs. 0.01 Cr Rs. 0.73 Cr Rs. 0.12 Cr -83.56 % + 1100 %
EPS in Rs Rs. 0 Rs. 0.01 Rs. 0.01 + 0 % 0 %


In reviewing EVEXIA LIFECARE LIMITED’s 2024-25(Q3) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 214.36 % year-on-year growth, although there was a slight dip of -22.41 % from the previous quarter. Expenses rose by 216.62 % compared to the previous year, with a decrease of -19.9 % quarter-on-quarter. Operating Profit surged by 70 % annually, and saw a -84.4 % decrease from the last quarter.
Net Profit showed yearly increase of 1100 %, and experienced a -83.56 % decrease from the previous quarter. however rose by 0 % compared to the last quarter. In essence, while EVEXIA LIFECARE LIMITED exhibits strong annual growth indicators, short-term fluctuations suggest the need for agile strategies to navigate market dynamics effectively. That’s all for now in the financial sector.

Join our telegram for more updates

Stay Updated with Our YouTube Videos

Related Post